 | ||
| Dear Investor, It's rare to find something in finance with a record-shattering, third-party verified 35+ year track record that still flies under the radar… But that's exactly what this is. Zacks Investment Research has a ranking system that's outperformed the S&P 500 every year since 1988… With average annual returns of +23.6%. {fname}, these numbers aren't cherry-picked… This Monday, their next batch of stock picks goes live - And for the first time ever, you can meet the entire team behind the strategy. Normally, this level of insight isn't offered to the everyday investor. But right now, for a limited time, it is. Click here to see the system and get the incredible guarantee that comes with it. Because yes - Zacks is now guaranteeing you'll beat the S&P 500 over the next 12 months… Or your money back. If you've been waiting for your chance to invest like the pros do, this is it. To your success,
P.S. If you've never heard of Zacks, that's no accident. Most pros don't want everyday investors getting access to tools like this, but that's too bad for them… Zacks' groundbreaking system is yours to follow - with your first picks starting Monday. | ||
 | ||
| ¹ The results listed above are not (or may not be) representative of the performance of all selections made by Zacks Investment Research's newsletter editors and may represent the partial close of a position. This free resource is being sent by Zacks.com. We look for investment resources and inform you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms of Service". https://www.zacks.com/terms_of_service Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research is not a licensed securities dealer, broker or U.S. investment adviser or investment bank. The Zacks #1 Rank Performance covers the period beginning on January 1, 1988 through June 2, 2025. The performance is the equal weighted performance of a hypothetical portfolio consisting of stocks with a Zacks Rank of #1 that was rebalanced monthly from January 1988 through December 2013 and weekly from 12/31/13 through Monday's open on June 2, 2025. For each stock with a Zacks Rank #1 at the beginning of the month, the total return during the month was calculated as the % change in the price of the stock from the closing price of the prior month to the closing price of the current month plus any dividends received during the month. The monthly individual stock returns were then averaged to determine the portfolio return for the month. For each stock with a Zacks Rank #1 at the beginning of the week, the total return during the week was calculated as the % change in the price of the stock from the opening price for the week to the opening price of the next week plus any dividends received during the week. The weekly individual stock returns were then averaged to determine the portfolio return for the week. If no month-end price or week end open price was available for a stock, it was not included in the portfolio return for the month or the week. The monthly and weekly returns were compounded to arrive at the annual returns. The annualized return is the annual return that, had it been achieved in each year or portion of a year, would have compounded to create the total return over the full time period. These returns are based on the list of Zacks Rank #1 Stocks that was available to clients of Zacks as of the beginning of the month, when returns were calculated monthly, or as of the beginning of the week when returns were calculated weekly. These returns are higher than the returns an investor could achieve investing real money in a portfolio of Zacks Rank #1 stocks because the returns of the hypothetical Zacks Rank #1 portfolio exclude a number of costs, including commissions incurred for trading, the average bid ask spread, the price impact of the trading and, prior to 2013, in those months when the end of the month fell on Friday, Saturday or Sunday, the overnight return from the month end close to the open on the next trading day. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance_disclosure for information about the performance numbers displayed above. Zacks Emails Zacks Investment Research |
Big Rallies Brewing? 3 Analyst Favorites to Watch Closely
Written by Nathan Reiff. Published 8/18/2025.
Key Points
- Three companies recently reporting earnings saw noticeable spikes in share price, drawing investor interest.
- SkyWater Technology, Emergent BioSolutions, and Backblaze enjoy analyst support and have room for further upside.
- These firms represent critical industries including U.S. semiconductor manufacturing, public health, and cloud storage.
While timing a rally is notoriously tricky, catalyzing events like earnings reports can sometimes be helpful landmarks for investors.
Companies can receive a big boost on impressive results or promising news, and then it is a matter of maintaining momentum to ensure those gains aren't given back shortly after.
Below, we look at three companies that may be positioned to continue to flourish after recent price spikes, thanks to promising emerging fundamentals and strong bullish sentiment from analysts.
A Dominant Position in U.S. Semiconductor Manufacturing
SkyWater Technology Inc. (NASDAQ: SKYT) provides semiconductor manufacturing services. The company had what was in many ways a lackluster period for the second quarter of 2025. Reporting in early August, SkyWater revealed that losses per share widened considerably as revenue dropped by 37% year-over-year (YOY). One bright spot in SkyWater's financials was gross margin, which improved by 20 basis points YOY to 18.5%. Nonetheless, SkyWater said its results were at the upper end of its expectations.
Investors responded to the earnings news by sending SKYT shares skyrocketing by about 30% in the last month. So why the bullish response? It could be that SkyWater also announced in its report that it had completed the acquisition of a flagship manufacturing facility, Fab 25, from German semiconductor maker Infineon Technologies AG (OTCMKTS: IFNNY). Fab 25 is expected to contribute at least $300 million in annual revenue and to give a big boost to EBITDA, with the impact likely emerging as early as the current quarter.
SkyWater's Fab 25 purchase will help to facilitate its multi-year supply agreement of over $1 billion and, perhaps even more importantly, positions the firm exceptionally well to deliver as changing U.S. regulations push firms toward onshore manufacturing of semiconductors and related components. Given that, it's no surprise that all three analysts reviewing SKYT shares have assigned them a Buy rating, and the rally over the last several weeks, which is already massive, could have reason to continue.
Growing International Business and Successful Expense Trimming
Life sciences firm Emergent BioSolutions Inc. (NYSE: EBS) is known for public health products, including NARCAN nasal spray for treatment of opioid overdose and vaccines and treatments for cholera, typhoid fever, and a range of other diseases. Emergent is coming off of a second quarter that, while yielding mixed results, nonetheless shows important advancements that could yield benefits into the future.
The company missed on revenue in the last quarter, but made notable improvements in EPS, reporting a positive figure when analysts expected a loss and beating predictions by 42 cents per share. The improvement was driven by strong NARCAN sales and, notably, cost optimization strategies and divestments, which substantially reduced expenses and allowed Emergent to launch a $50-million share repurchase program. Liquidity and net leverage are also improving.
Emergent's international medical countermeasures business is rapidly growing. The company recently secured a $65-million contract with the Ontario Ministry of Health for NARCAN and additional revenue-generating contract modifications. With all three analysts reviewing EBS shares rating them a Buy, the company has upside potential of more than 62% despite already climbing more than 21% in the past month.
Despite Mixed Earnings, a Strong Growth Trajectory and Improving Profitability Metrics
Cloud storage provider Backblaze Inc. (NASDAQ: BLZE) noted 16% YOY revenue improvement and a top-line beat in its latest earnings, delivered early in August 2025. The company has netted new high-ARR customers thanks to increasing demand due to AI, helping its storage revenue to surge by 29%. On the other hand, GAAP losses per share came in wider than expected.
Still, profitability metrics like adjusted EBITDA margin are improving overall, and the company's B2 OverDrive platform has launched successfully, including an early six-figure customer in the first weeks of launch. This is a positive sign that Backblaze will be able to continue to build out its infrastructure and scale its offerings. Investors will certainly keep an eye on the company's free cash flow in this process, however, as that has so far remained frustratingly negative.
With one-month gains of more than 48%, Backblaze shares seem to have lit a fire. The company has a unanimous Buy rating from all seven analysts, and a consensus price target above $10 per share would suggest an additional 31% in upside is possible.
This email message is a paid sponsorship sent on behalf of Zacks, a third-party advertiser of The Early Bird and MarketBeat.
If you need help with your newsletter, please feel free to contact MarketBeat's South Dakota based support team at contact@marketbeat.com.
If you no longer wish to receive email from The Early Bird, you can unsubscribe.
© 2006-2025 MarketBeat Media, LLC. All rights reserved.
345 North Reid Place #620, Sioux Falls, SD 57103. United States of America..
0 Response to "The stock system that beat the S&P by 5,400%"
Post a Comment